CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
RESPINE aims to develop an effective treatment for degenerative disc disease using allogenic mesenchymal stem cells. The project focuses on a clinical trial to assess pain and disability reduction, providing a minimally invasive therapy option for patients.
The World Health Organisation (WHO) has included low back pain in its list of twelve priority diseases.
Notably, Degenerative disc disease (DDD) presents a large, unmet medical need which results in a disabling loss of mechanical function.
Today, no efficient therapy is available.
Chronic cases often receive surgery, which may lead to biomechanical problems and accelerated degeneration of adjacent segments.
Our consortium partners have developed and studied stem cell-based, regenerative therapie…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, Pamplona
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Spain, VALLADOLID
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
France, Toulouse
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Ireland, Galway
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
